Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LARS FREISBERG

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1659325454
CMS profile
210343
Location
TULSA, OK

General Payments · PY2018–2022

$6,554.32

  • Reported across 52 records
  • CMS publication 2026-01-23

Latest program year · PY2022

$2,611.47

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Current or prospective ownership or investment interest $2,327.45 2
Food and Beverage $284.02 14

By paying entity

PY2022 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $319.97 16
PY2019 $1,333.47 11
PY2020 $737.26 2
PY2021 $1,552.15 7
PY2022 $2,611.47 16

Payment records · PY2022 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2022 2018201920202021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.87 10/11/2022 Food and Beverage Undisputed 01/23/2026 890985117 CMS
Alimera Sciences, Inc. $21.34 02/08/2022 Food and Beverage Undisputed 01/23/2026 896603721 CMS
Alimera Sciences, Inc. $21.06 03/17/2022 Food and Beverage Undisputed 01/23/2026 896603943 CMS
Alimera Sciences, Inc. $21.18 09/29/2022 Food and Beverage Undisputed 01/23/2026 896604063 CMS
Alimera Sciences, Inc. $16.89 10/27/2022 Food and Beverage Undisputed 01/23/2026 896603881 CMS
Bausch & Lomb Americas Inc. $15.99 04/13/2022 Food and Beverage Undisputed 01/23/2026 957508369 CMS
EyePoint Pharmaceuticals US, Inc. $24.40 03/08/2022 Food and Beverage Undisputed 01/23/2026 932995415 CMS
EyePoint Pharmaceuticals US, Inc. $24.27 11/01/2022 Food and Beverage Undisputed 01/23/2026 932992401 CMS
Genentech USA, Inc. $18.79 02/08/2022 Food and Beverage Undisputed 01/23/2026 950802297 CMS
Genentech, Inc. $21.47 03/08/2022 Food and Beverage Undisputed 01/23/2026 950794493 CMS
Regeneron Healthcare Solutions, Inc. $20.27 01/26/2022 Food and Beverage Undisputed 01/23/2026 927169197 CMS
Regeneron Healthcare Solutions, Inc. $23.38 04/07/2022 Food and Beverage Undisputed 01/23/2026 927169201 CMS
Regeneron Healthcare Solutions, Inc. $21.43 08/09/2022 Food and Beverage Undisputed 01/23/2026 927169205 CMS
Regeneron Healthcare Solutions, Inc. $15.68 12/15/2022 Food and Beverage Undisputed 01/23/2026 927169209 CMS
US Retina LLC $303.50 04/12/2022 Current or prospective ownership or investment interest Undisputed 01/23/2026 952014607 CMS
US Retina LLC $2,023.95 04/13/2022 Current or prospective ownership or investment interest Undisputed 01/23/2026 952013781 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.